BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28452170)

  • 1. Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.
    White V; Marco DJT; Bolton D; Davis ID; Jefford M; Hill D; Prince HM; Millar JL; Winship IM; Coory M; Giles GG
    BJU Int; 2017 Nov; 120 Suppl 3():6-14. PubMed ID: 28452170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.
    Filson CP; Schwartz K; Colt JS; Ruterbusch J; Linehan WM; Chow WH; Miller DC
    Urol Oncol; 2014 Jan; 32(1):27.e15-21. PubMed ID: 23419677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).
    Schiavina R; Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Brunocilla E; Fiori C; Longo N; Martorana G; Mirone V; Morgia G; Novara G; Porpiglia F; Rovereto B; Serni S; Simeone C; Sodano M; Terrone C; Carini M; Minervini A
    Eur J Surg Oncol; 2015 Mar; 41(3):346-52. PubMed ID: 25583459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
    Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
    Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.
    White VM; Marco DJT; Bolton D; Papa N; Neale RE; Coory M; Davis ID; Wood S; Giles GG; Jordan SJ
    BJU Int; 2018 Nov; 122 Suppl 5():50-61. PubMed ID: 30307688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of localised renal cell carcinoma.
    Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
    Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
    Whitson JM; Harris CR; Meng MV
    BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline.
    Capitanio U; Larcher A; Terrone C; Antonelli A; Volpe A; Fiori C; Furlan M; Dehò F; Minervini A; Serni S; Porpiglia F; Trevisani F; Salonia A; Carini M; Simeone C; Montorsi F; Bertini R
    Eur Urol; 2016 Oct; 70(4):558-561. PubMed ID: 27021797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron Sparing Surgery Has Better Oncologic Outcomes Than Extirpative Nephrectomy in T1a but Not in T1b or T2 Stage Renal Cell Carcinoma.
    Luo Y; Chen SS; Bai L; Luo L; Zheng XG; Wang S
    Med Sci Monit; 2017 Jul; 23():3480-3488. PubMed ID: 28717119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy.
    Fedeli U; Novara G; Alba N; Ficarra V; Artibani W; Spolaore P
    BJU Int; 2010 May; 105(9):1255-9. PubMed ID: 19818073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
    Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
    Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of low-stage renal cell carcinoma: Technology does not supersede biology.
    Hollingsworth JM; Miller DC; Dunn RL; Montgomery JS; Roberts WW; Hafez KS; Wolf JS
    Urology; 2006 Jun; 67(6):1175-80. PubMed ID: 16765177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of of nephron-sparing surgery (NSS) at an Australian tertiary referral centre: an analysis of surgical decision-making using the R.E.N.A.L. nephrometry scoring system.
    Satasivam P; Rajarubendra N; Chia PH; Munshey A; Sengupta S; Bolton D
    BJU Int; 2012 May; 109(9):1341-4. PubMed ID: 21951826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.